News
3h
Zacks Investment Research on MSNNovo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock?Novo Nordisk NVO shares have lost 16.7%, attributable to both sector-specific developments and broader macroeconomic ...
“While there’s still a lot to learn, these findings show that regular intensity exercise, even at low intensity, could go a ...
Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca ...
U.S. electric and gas utility CMS Energy on Thursday reported a rise in first-quarter profit, helped by higher power demand.
Along with the rest of the market, Novo Nordisk (NYSE:NVO) has been sinking this year – with losses approaching 30% ...
Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.
Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...
The bill creates an efficiency office to streamline Texas regulations, reduce unnecessary rules and improve public access to ...
Several hundred units of counterfeit Ozempic (semaglutide 1mg injection) were seized by the Food and Drug Administration.
FDA Commissioner Marty Makary talks about his plans to revamp drug development and reduce ‘conflicts of interest’ between the ...
Furthermore, Novo Nordisk should earn important label expansions for some of its current medicines while developing new ones in other areas. Semaglutide is being tested in Alzheimer's disease. And the ...
SAP shares surged after the German business-software group posted a first-quarter operating profit above analysts' expectations and backed its full-year guidance, reassuring investors that the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results